Dimethylamine

Dimethylamine

SCHEMBL5202356

CNC.O=Cc1cccc(Cl)c1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 1/20 0.50
CYP1A2 P05177 3/20 0.48
CYP2C9 P11712 1/20 0.48
ALDH1A1 P00352 2/20 0.47
FBP1 P09467 2/20 0.46
CHAT P28329 1/20 0.46
RELA Q04206 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 1/20 0.43
UNG P13051 1/20 0.42
MAOB P27338 2/20 0.42
CYP1A1 P04798 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP1B1 Q16678 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethane SCHEMBL2153770 0.91 CHRM5 (0.54) CHRM5CYP1A2CYP2C9ALDH1A1FBP1
SCHEMBL40399 0.91
SCHEMBL29672621 0.91
Benzaldehyde SCHEMBL20557183 0.85 ALDH1A1 (0.61) CHRM5CYP1A2CYP2C9ALDH1A1FBP1
SCHEMBL28276590 0.83 HSD17B10 (0.67) CHRM5CYP1A2CYP2C9ALDH1A1FBP1
SCHEMBL18530648 0.83 CYP1A2 (0.53) CHRM5CYP1A2CYP2C9ALDH1A1FBP1
Ethylene Glycol SCHEMBL28617308 0.82 CYP1A2 (0.52) CHRM5CYP1A2CYP2C9ALDH1A1FBP1
Heptane SCHEMBL28304085 0.81 EPHX1 (0.47) CHRM5CYP1A2CYP2C9KMT2A
SCHEMBL10860684 0.80 RELA (0.46) CHRM5CYP1A2CYP2C9ALDH1A1FBP1
SCHEMBL1443724 0.79 TRIM24 (0.53) CHRM5CYP1A2CYP2C9ALDH1A1FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1150996-B1 NEW AMIDINOBENZYLAMINE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS ASTRAZENECA AB (SE) 2007-11-21 EP disclosed
US-6599894-B1 Competitive inhibitors of trypsin-like proteases, such as thrombin, and in treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants AstŕaZeneca AB (SE) 2003-07-29 US disclosed
EP-1150996-A1 NEW AMIDINOBENZYLAMINE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS AstraZeneca AB (SE) 2001-11-07 EP disclosed
WO-2000042059-A1 NEW AMIDINOBENZYLAMINE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS ASTRAZENECA AB (SE) 2000-07-20 WO disclosed